Physician group Cellular Medicine Association stated on Monday that the US FDA has approved the use of the plasma (convalescent plasma) from the survivors of COVID-19 to be given as a life-saving treatment to those who may still be fighting to survive acute COVID-19 infection.
Cellular Medicine Association said people who survive COVID-19 harbor antibodies in their blood that fought the virus and won. Physicians struggle to quickly find the blood of a local person who has survived COVID-19 and who can donate the life-saving convalescent plasma, but the survivors do not know where to go to donate their blood.
The organisation has built a website, COVID19Switchboard.org, that connects those looking for blood and those wanting to give blood. This free switchboard works in every country (using Google Translate).
About 2000 company physicians and nurse practitioners in over 50 countries focus on connect potential donors with physicians through the procedures invented by Dr Runels--the Vampire Facelift, the Vampire Facial, the O-Shot and the Priapus Shot.
Nicox completes key data package for NCX 470 NDA submissions
Immusoft's ISP-002 granted US FDA Orphan Drug Designation in MPS II
Orphan Therapeutics Accelerator signs MoU with Fondazione Telethon
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
Sobi s Aspaveli marketing authorisation receives positive European regulatory opinion
BioCryst wins FDA approval for oral HAE prophylaxis in young children
NanOlogy launches drug development program for diffuse intrinsic pontine glioma treatment